⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20508886 | 1.00 | — | — | |
| SCHEMBL6575662 | 1.00 | — | — | |
| SCHEMBL9123361 | 0.83 | KDM4E (0.41) | — | |
| SCHEMBL3439556 | 0.81 | KDM4E (0.52) | — | |
| SCHEMBL24817200 | 0.80 | — | — | |
| SCHEMBL21216105 | 0.80 | ACE (0.38) | — | |
| SCHEMBL3458343 | 0.79 | — | — | |
| SCHEMBL23152669 | 0.79 | — | — | |
| SCHEMBL157552 | 0.78 | KDM4E (0.50) | — | |
| SCHEMBL2597731 | 0.78 | KDM4E (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150150770-A1 | METHODS OF TREATING SKIN | TRACIE MARTYN INTERNATIONAL INC (US) | 2015-06-04 | — | — | US | disclosed |
| US-20140155961-A1 | METHODS OF TREATING SKIN | Tracie Martyn International, Inc. (US) | 2014-06-05 | — | — | US | disclosed |
| US-20100272790-A1 | Methods of Treating Skin | TRACIE MARTYN INTERNATIONAL, LLC (US) | 2010-10-28 | — | — | US | disclosed |
| US-7776915-B2 | Topical formulations and methods of use | TRACIE MARTYN INTERNATIONAL, LLC (US) | 2010-08-17 | — | — | US | disclosed |
| US-20060216251-A1 | Topical formulations and methods of use | TRACIE MARTYN INTERNATIONAL, LLC (US) | 2006-09-28 | — | — | US | disclosed |
| WO-1999021008-A1 | PHARMACEUTICAL GRADE GARLIC | PHARMAPRINT, INC. (US) | 1999-04-29 | — | — | WO | disclosed |
| US-5385933-A | Method for the treatment of cancer by use of the copper complex of S-(methylthio)-DL-homocysteine or the L-enantiomorph thereof | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-01-31 | — | — | US | disclosed |
| US-5124351-A | Containing copper chelate of nitrilotriacetic acid or bis-thiosemicarbazone | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-06-23 | — | — | US | disclosed |
| US-4304692-A | RESIN PEPTIDE FOR MAKING CALCITONIN ANALOGUES | ARMOUR PHARMACEUTICAL COMPANY (US) | 1981-12-08 | — | — | US | disclosed |
| US-4239680-A | CALCITONIN ACITIVITY | ARMOUR AND COMPANY (US) | 1980-12-16 | — | — | US | disclosed |